Clinical Ink is a leading provider of innovative eSource solutions for decentralized clinical trials, connecting data and operations to streamline the clinical trial process. Their eSource ecosystem integrates Direct Data Capture (DDC) technology and electronic Clinical Outcome Assessments (eCOA) to capture high-quality clinical trial data directly from patients, resulting in faster and more efficient studies.
With a focus on therapeutic areas such as diabetes, immunology, infectious disease, neurology, and oncology, Clinical Ink's eSource methods enable the ingestion of data from multiple sources, facilitating decentralized trials and improving data analytics. Their comprehensive suite of solutions, including eCOA, eConsent, eLAS Suite, mobile devices, and televisit capabilities, ensures simplified study startup, standardized processes, and enhanced patient engagement.
Generated from the website